Literature DB >> 1580222

[Aniseikonia of central serous chorioretinopathy].

H Hisada1, S Awaya.   

Abstract

Central serous chorioretinopathy (CRS) is one of the typical diseases that accompany micropsia. However very little is known about micropsia of CRS, because of the difficulty to measure "aniseikonia" in terms of micropsia. Aniseikonia in 65 cases of CRS was measured quantitatively by Awaya's New Aniseikonia Tests (NAT). The tests were performed at two different distances of 40 cm (visual angle: 6 degrees) and 20 cm (12 degrees) and under 4 meridians of the halfmoon on NAT, horizontal, 45 degrees, vertical and 135 degrees, respectively. The mean value of aniseikonia under each testing condition was as follows: 6 degrees horizontal -3.13%, 45 degrees -2.56%, vertical -2.13%, 135 degrees -2.57%, 12 degrees; horizontal -1.38%, 45 degrees -1.69%, vertical -1.84%, 135 degrees -1.50%. At 6 degrees aniseikonia is larger in the horizontal meridian than in the vertical with statistical significance (t-test, p less than 0.05), while at 12 degrees aniseikonia is smaller than at 6 degrees and shows no particular tendency in terms of meridian. The phenomenon observed at 6 degrees may be what is called "oriented metamorphopsia".

Entities:  

Mesh:

Year:  1992        PMID: 1580222

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  7 in total

1.  Comparison of visual acuity, metamorphopsia, and aniseikonia in patients with an idiopathic epiretinal membrane.

Authors:  Atsuhiro Tanikawa; Yoshiaki Shimada; Masayuki Horiguchi
Journal:  Jpn J Ophthalmol       Date:  2018-04-06       Impact factor: 2.447

2.  Aniseikonia associated with epiretinal membranes.

Authors:  M Ugarte; T H Williamson
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Aniseikonia in various retinal disorders.

Authors:  Fumiki Okamoto; Yoshimi Sugiura; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-25       Impact factor: 3.117

4.  Aniseikonia following intravitreal ranibizumab treatment for branch retinal vein occlusion.

Authors:  Shohei Morikawa; Fumiki Okamoto; Tomoya Murakami; Yoshimi Sugiura; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2021-07-12       Impact factor: 2.447

5.  Evaluation of aniseikonia with an auto-stereoscopic smartphone.

Authors:  Lingzhi Zhao; Huang Wu
Journal:  Ann Transl Med       Date:  2019-11

6.  Long-term functional outcomes and vision-related quality of life after vitrectomy for epiretinal membrane: a prospective cohort study.

Authors:  Raoul Kanav Khanna; Marta Dorvault; Jeremy Pasco; Ann-Rose Cook; Tiphanie Pichard; Marie-Thérèse Marotte; Pierre-Jean Pisella; Sophie Arsene
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

7.  Relationship between stereopsis and vision-related quality of life in patients with branch retinal vein occlusion.

Authors:  Shohei Morikawa; Fumiki Okamoto; Tomoya Murakami; Yoshimi Sugiura; Takahiro Hiraoka; Yoshifumi Okamoto; Tetsuro Oshika
Journal:  BMJ Open Ophthalmol       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.